FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36885411000001103: Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1862781000001112 Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1862791000001114 Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Cisatracurium besilate 20mg/10ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has active ingredient Cisatracurium true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has specific active ingredient Cisatracurium besilate true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cisatracurium true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) 5 ampoule Has AMP True Cisatracurium besilate 20mg/10ml solution for injection ampoules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start